FDA NDC Directory · JSON-LD · Markdown
NDC 69367-417 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE
| Labeler / Manufacturer | Westminster Pharmaceuticals, LLC |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA205468 |
| Dosage form / route | TABLET, EXTENDED RELEASE · ORAL |
| Active ingredients | VENLAFAXINE HYDROCHLORIDE (150 mg/1) |
| Marketing started | 20251118 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).